CDH1 and neoplasm: Furthermore, Cdh1 protein, whose loss is a key contributor to EMT, tumor malignancy, and progression47,48, was also substantially downregulated in islets and tumors (Figs. 3b, 4c, d; Supplementary Figure 3a, b).